Our ophthalmic portfolio includes below products.
|Olopatadine Hcl||0.1 % ophthalmic solution|
|Olopatadine Hcl||0.2% ophthalmic solution|
US: Filed 2 ANDAs, 1 approved, 1 launched, 1 under review
EU/UK: 1 Filed, 1 approved, 1 commercial (4 MAs of ophthalmic products)
For more information about our existing portfolio and our pipeline products please e-mail us at email@example.com
Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.